Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: Big Kahuna who wrote (7523)	4/26/1999 7:01:00 PM
From: Mkilloran	Read Replies (1) \| Respond to of 9523

Big Kahuna...may be the article in the NY Times today on Vivus patent for Female Sexual disfunction. Take a little wind out of Viagra for women as a big moneymaker for PFE.

To: Big Kahuna who wrote (7523)	4/26/1999 7:49:00 PM
From: Brander	Respond to of 9523

Meanwhile, the pharmaceutical sector continues to slump. Warner-Lambert (NYSE:WLA) lost $1 to $66.88 despite posted earnings a penny ahead of expectations, but below lasts year's number. Analysts are worried about a slowdown in revenues for the second half of the year. Pfizer (NYSE:PFE) fell $3.19 to $123.81. Shares of Merck (NYSE:MRK) dropped $1.75 to $74.

To: Big Kahuna who wrote (7523)	4/26/1999 7:53:00 PM
From: BigKNY3	Respond to of 9523

Big Kahuna <<Any reason we got beat up a little today?>> Big: It is virtually impossible to place a cause and effect on a newsless trading day. You can take your pick among the following: 1. Market noise 2. Profit-taking from last week's 12% gain off the Valley 3. Big Pharma sector rotation 4. The pending Vioxx approval 5. All of the above 6. None of the above BigKNY3